Search Results - "HANSEN, Bettina"

Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis by Tanaka, Atsushi, Hirohara, Junko, Nakano, Toshiaki, Matsumoto, Kosuke, Chazouillères, Olivier, Takikawa, Hajime, Hansen, Bettina E., Carrat, Fabrice, Corpechot, Christophe

“…A beneficial effect of bezafibrate (BZF) on symptoms and biochemical features of primary biliary cholangitis (PBC) has been reported in patients with an…”
Get full text

Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy by Papatheodoridis, George V, Chan, Henry Lik-Yuen, Hansen, Bettina E, Janssen, Harry L.A, Lampertico, Pietro

“…Summary In the treatment of chronic hepatitis B (CHB), the ultimate goal is preventing hepatitis B virus (HBV)-associated liver disease, including…”
Get full text

Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study) by Liem, Kin Seng, Fung, Scott, Wong, David K, Yim, Colina, Noureldin, Seham, Chen, Jiayun, Feld, Jordan J, Hansen, Bettina E, Janssen, Harry L A

“…Although most patients with chronic hepatitis B (CHB) reach effective virological suppression with long-term nucleos(t)ide analogues (NA) therapy, some might…”
Get more information

Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival by Montano-Loza, Aldo J., Hansen, Bettina E., Corpechot, Christophe, Roccarina, Davide, Thorburn, Douglas, Trivedi, Palak, Hirschfield, Gideon, McDowell, Patrick, Poupon, Raoul, Dumortier, Jerome, Bosch, Alexie, Giostria, Emiliano, Conti, Filomena, Parés, Albert, Reig, Anna, Floreani, Annarosa, Russo, Francesco Paolo, Goet, Jorn C., Harms, Maren H., van Buuren, Henk, Van den Ende, Natalie, Nevens, Frederik, Verhelst, Xavier, Donato, Maria Francesca, Malinverno, Federica, Ebadi, Maryam, Mason, Andrew L.

“…Primary biliary cholangitis (PBC) frequently recurs after liver transplantation. We evaluated risk factors associated with recurrence of PBC and its effects…”
Get full text

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy by Papatheodoridis, George, Dalekos, George, Sypsa, Vana, Yurdaydin, Cihan, Buti, Maria, Goulis, John, Calleja, Jose Luis, Chi, Heng, Manolakopoulos, Spilios, Mangia, Giampaolo, Gatselis, Nikolaos, Keskin, Onur, Savvidou, Savvoula, de la Revilla, Juan, Hansen, Bettina E, Vlachogiannakos, Ioannis, Galanis, Kostantinos, Idilman, Ramazan, Colombo, Massimo, Esteban, Rafael, Janssen, Harry L.A, Lampertico, Pietro

“…Graphical abstract…”
Get full text

Time to diagnosis and treatment in younger adults with colorectal cancer: A systematic review by Castelo, Matthew, Sue-Chue-Lam, Colin, Paszat, Lawrence, Kishibe, Teruko, Scheer, Adena S, Hansen, Bettina E, Baxter, Nancy N

“…The incidence of colorectal cancer is rising in adults <50 years of age. As a primarily unscreened population, they may have clinically important delays to…”
Get full text

Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment by Spaan, Michelle, van Oord, Gertine, Kreefft, Kim, Hou, Jun, Hansen, Bettina E., Janssen, Harry L. A., de Knegt, Robert J., Boonstra, Andre

“…Background. Chronic hepatitis C virus (HCV) infection is a global health problem, resulting in liver failure, hepatocellular carcinoma, and liver-related…”
Get full text

External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study by Koehler, Edith M, Schouten, Jeoffrey N.L, Hansen, Bettina E, Hofman, Albert, Stricker, Bruno H, Janssen, Harry L.A

“…Background & Aims We aimed to validate the fatty liver index (FLI), an algorithm that is based on waist circumference, body mass index, and levels of…”
Get full text

Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B by Choi, Hannah S.J., Brouwer, Willem P., Zanjir, Wayel M.R., Man, Robert A., Feld, Jordan J., Hansen, Bettina E., Janssen, Harry L.A., Patel, Keyur

“…Background and Aims Chronic hepatitis B (CHB) and nonalcoholic fatty liver disease are increasingly observed together in clinical practice, and development of…”
Get full text

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B by Papatheodoridis, George V., Idilman, Ramazan, Dalekos, George N., Buti, Maria, Chi, Heng, van Boemmel, Florian, Calleja, Jose Luis, Sypsa, Vana, Goulis, John, Manolakopoulos, Spilios, Loglio, Alessandro, Siakavellas, Spyros, Keskın, Onur, Gatselis, Nikolaos, Hansen, Bettina E., Lehretz, Maria, de la Revilla, Juan, Savvidou, Savvoula, Kourikou, Anastasia, Vlachogiannakos, Ioannis, Galanis, Kostantinos, Yurdaydin, Cihan, Berg, Thomas, Colombo, Massimo, Esteban, Rafael, Janssen, Harry L.A., Lampertico, Pietro

“…Whether there is a change of hepatocellular carcinoma (HCC) incidence in chronic hepatitis B patients under long‐term therapy with potent nucleos(t)ide…”
Get full text

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis by Harms, Maren H., van Buuren, Henk R., Corpechot, Christophe, Thorburn, Douglas, Janssen, Harry L.A., Lindor, Keith D., Hirschfield, Gideon M., Parés, Albert, Floreani, Annarosa, Mayo, Marlyn J., Invernizzi, Pietro, Battezzati, Pier Maria, Nevens, Frederik, Ponsioen, Cyriel Y., Mason, Andrew L., Kowdley, Kris V., Lammers, Willem J., Hansen, Bettina E., van der Meer, Adriaan J.

“…[Display omitted] •Ursodeoxycholic acid is associated with prolonged survival in primary biliary cholangitis.•This positive association is significant…”
Get full text

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis by Sharma, Suraj A., Kowgier, Matthew, Hansen, Bettina E., Brouwer, Willem Pieter, Maan, Raoel, Wong, David, Shah, Hemant, Khalili, Korosh, Yim, Colina, Heathcote, E. Jenny, Janssen, Harry L.A., Sherman, Morris, Hirschfield, Gideon M., Feld, Jordan J.

“…[Display omitted] •HCC incidence varies markedly by etiology of cirrhosis.•THRI is simple to use, has good predictive ability, and has been externally…”
Get full text

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis by van der Meer, Adriaan J, Veldt, Bart J, Feld, Jordan J, Wedemeyer, Heiner, Dufour, Jean-François, Lammert, Frank, Duarte-Rojo, Andres, Heathcote, E. Jenny, Manns, Michael P, Kuske, Lorenz, Zeuzem, Stefan, Hofmann, W. Peter, de Knegt, Robert J, Hansen, Bettina E, Janssen, Harry L. A

“…CONTEXT Chronic hepatitis C virus (HCV) infection outcomes include liver failure, hepatocellular carcinoma (HCC), and liver-related death. OBJECTIVE To assess…”
Get full text

Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity by Krassenburg, Lisette A.P., Maan, Raoel, Ramji, Alnoor, Manns, Michael P., Cornberg, Markus, Wedemeyer, Heiner, de Knegt, Robert J., Hansen, Bettina E., Janssen, Harry L.A., de Man, Robert A., Feld, Jordan J., van der Meer, Adriaan J.

“…HCV-infected patients with cirrhosis achieve high sustained virological response (SVR) rates with direct-acting antivirals (DAAs) even after hepatic…”
Get full text

Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy by Lammers, Willem J, Hirschfield, Gideon M, Corpechot, Christophe, Nevens, Frederik, Lindor, Keith D, Janssen, Harry L.A, Floreani, Annarosa, Ponsioen, Cyriel Y, Mayo, Marlyn J, Invernizzi, Pietro, Battezzati, Pier M, Parés, Albert, Burroughs, Andrew K, Mason, Andrew L, Kowdley, Kris V, Kumagi, Teru, Harms, Maren H, Trivedi, Palak J, Poupon, Raoul, Cheung, Angela, Lleo, Ana, Caballeria, Llorenç, Hansen, Bettina E, van Buuren, Henk R

“…Background & Aims Approaches to risk stratification for patients with primary biliary cirrhosis (PBC) are limited, single-center based, and often dichotomous…”
Get full text

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity by Santer, Deanna M., Li, Daniel, Ghosheh, Yanal, Zahoor, Muhammad Atif, Prajapati, Dhanvi, Hansen, Bettina E., Tyrrell, D. Lorne J., Feld, Jordan J., Gehring, Adam J.

“…Interferons induced early after SARS-CoV-2 infection are crucial for shaping immunity and preventing severe COVID-19. We previously demonstrated that injection…”
Get full text

Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy by Chi, Heng, Li, Zhandong, Hansen, Bettina E., Yu, Tao, Zhang, Xiaoyong, Sun, Jian, Hou, Jinlin, Janssen, Harry L.A., Peng, Jie

“…Levels of antibodies against the hepatitis B virus (HBV) core protein (anti-HBc) have been associated with response to nucleos(t)ide analogue and…”
Get full text

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B by Papatheodoridis, George V., Sypsa, Vana, Dalekos, George N., Yurdaydin, Cihan, Van Boemmel, Florian, Buti, Maria, Calleja, Jose Luis, Chi, Heng, Goulis, John, Manolakopoulos, Spilios, Loglio, Alessandro, Voulgaris, Theodoros, Gatselis, Nikolaos, Keskin, Onur, Veelken, Rhea, Lopez-Gomez, Marta, Hansen, Bettina E., Savvidou, Savvoula, Kourikou, Anastasia, Vlachogiannakos, John, Galanis, Kostas, Idilman, Ramazan, Esteban, Rafael, Janssen, Harry L.A., Berg, Thomas, Lampertico, Pietro

“…Hepatocellular carcinoma (HCC) may develop in patients with chronic hepatitis (CHB) even after 5 years of oral therapy and cannot be easily predicted. We…”
Get full text

Comparing Time to Diagnosis and Treatment Between Younger and Older Adults With Colorectal Cancer: A Population-Based Study by Castelo, Matthew, Paszat, Lawrence, Hansen, Bettina E., Scheer, Adena S., Faught, Neil, Nguyen, Lena, Baxter, Nancy N.

“…Younger adults (aged <50 years) with colorectal cancer (CRC) may have prolonged delays to diagnosis and treatment that are associated with adverse outcomes. We…”
Get full text

Dynamic risk profiling of HCC recurrence after curative intent liver resection by Ivanics, Tommy, Murillo Perez, Carla Fiorella, Claasen, Marco P. A. W., Patel, Madhukar S., Morgenshtern, Gabriela, Erdman, Lauren, Shwaartz, Chaya, Rajendran, Luckshi, O’Kane, Grainne M., Hansen, Bettina E., Cleary, Sean P, Sapisochin, Gonzalo

“…Background and Aims Following liver resection (LR) for HCC, the likelihood of survival is dynamic, in that multiple recurrences and/or metastases are possible,…”
Get full text